✦ LIBER ✦

Clinical relevance of minimal residual disease monitoring in non-Hodgkin’s lymphomas: a critical reappraisal of molecular strategies

✍ Scribed by Corradini, P; Ladetto, M; Pileri, A; Tarella, C

Book ID: 110054343
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 84 KB
Volume: 13
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2401559

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantitative monitoring of cyclin D1 exp

Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma

✍ Helena Brizova; Marketa Kalinova; Lenka Krskova; Marcela Mrhalova; Roman Kodet 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 235 KB

## Abstract In mantle cell lymphoma (MCL), minimal residual disease (MRD) is an indicator of the disease outcome. Quantitative methods used so far do not provide a suitable molecular marker in 30–70% patients with MCL (depending on the technique used). We tested cyclin D1 as a marker for quantitati

Randomized trial of peripheral blood pro

Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin’s lymphoma and Hodgkin’s disease: a clinical and molecular analysis

✍ Kanteti, R; Miller, K B; McCann, J C; Roitman, D; Morelli, J; Hurley, C; Berkman 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Minimal disease assessment in the treatm

Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children’s oncology group report

✍ Bruce Shiramizu; Stanton Goldman; Ian Kusao; Melissa Agsalda; James Lynch; Lynet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB